(Q33419062)
Statements
1 reference
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma (English)
1 reference
Matthew I Milowsky
1 reference
Christian Dittrich
1 reference
Ignacio Durán
1 reference
Satinder Jagdev
1 reference
Frederick E Millard
1 reference
Christopher J Sweeney
1 reference
Dean Bajorin
1 reference
Linda Cerbone
1 reference
Walter M Stadler
1 reference
Melissa Lochheed
1 reference
Paramita Sen
1 reference
Matthew Squires
1 reference
Michael Shi
1 reference
Cora N Sternberg
1 reference
30 October 2014
1 reference
1 reference
Identifiers
1 reference